AI Analysis AI Analysis of ABBV AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ABBV to Watchlist?
Some Reasons Why To Add ABBV:
  • Excellent financial health (Piotroski 7/9)
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong return on equity of 68.0%
PDF

Red day on Tuesday for AbbVie stock after losing 1.31%
(Updated on Jul 14, 2026)

Buy or Hold candidate since Jun 03, 2026 Gain 12.72%

The AbbVie stock price fell by -1.31% on the last day (Tuesday, 14th Jul 2026) from $248.00 to $244.74. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 1.33% from a day low at $243.19 to a day high of $246.42. The price has fallen in 9 of the last 10 days and is down by -3.76% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $1.28 billion.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.91% during the next 3 months and, with a 90% probability hold a price between $290.92 and $336.65 at the end of this 3-month period.

ABBV Signals & Forecast

The AbbVie stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $250.39. On a fall, the stock will find some support from the long-term average at approximately $232.88. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -6.26%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AbbVie stock

AbbVie finds support from accumulated volume at $243.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.23 between high and low, or 1.33%. For the last week, the stock has had daily average volatility of 2.18%.

Our recommended stop-loss: $233.91 (-4.43%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (ABBV) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect AbbVie Inc to open at $244.78, and during the day (based on 14 day Average True Range), to move between $241.58 and $247.90, which gives a possible trading interval of +/-$6.33 (+/-2.62%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 2.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $243.14 (0.65%) than the resistance at $254.31 (3.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Dividend Warning For ABBV

Notice for ABBV: Ex-dividend date was Wednesday 15th July, 2026. The dividend was $1.73.

Is AbbVie Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AbbVie stock to perform well in the short-term.

Current score: 1.374 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 15, 2026 - $244.78 ( 0.0177%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ABBV Performance

Trading levels for ABBV

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 248.01 1.34%
R2 246.78 0.83%
R1 246.02 0.522%
Price 244.74
S1 243.55 -0.486%
S2 242.79 -0.798%
S3 241.55 -1.30%

Accumulated Volume Support & Resistance Levels

Level Price
R3 254.76 4.09%
R2 254.65 4.05%
R1 254.31 3.91%
Price 244.74
S1 243.14 -0.654%
S2 211.33 -13.65%
S3 204.35 -16.50%

ABBV Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 18, 2026 Jul 15, 2026 Aug 14, 2026 $1.73 0.752%
2 Feb 19, 2026 Apr 15, 2026 May 15, 2026 $1.73 0.754%
3 Oct 31, 2025 Jan 16, 2026 Feb 17, 2026 $1.73 0.82%
4 Sep 05, 2025 Oct 15, 2025 Nov 14, 2025 $1.64 0.782%
5 Jun 20, 2025 Jul 15, 2025 Aug 15, 2025 $1.64 0.88%

FAQ

What is the symbol for AbbVie Stock and on which exchange is it traded?
The symbol for AbbVie is ABBV and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AbbVie Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AbbVie stock to perform well in the short-term.

How to buy AbbVie Stock?
AbbVie Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AbbVie Stock.

What's the current price of AbbVie Stock?
As of the end of day on the Jul 14, 2026, the price of an AbbVie (ABBV) share was $244.74.

What is the 52-week high and low for AbbVie Stock?
The 52-week high for AbbVie Stock is $261.64 and the 52-week low is $184.65.

What is the market capitalization of AbbVie Stock?
As of the Jul 14, 2026, the market capitalization of AbbVie is 432.405B.

When is the next earnings date for AbbVie?
The upcoming earnings date for AbbVie is Jul 31, 2026.
Click to get the best stock tips daily for free!
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
5.52% Jun 29
ROP
$331.60
4.54% Jun 24
JLL
$299.78
4.87% Jun 24
NESR
$25.07
16.83% Jun 23
CAG
$13.43
5.36% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE